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Cancer patients receiving medical treatment at other centers now eligible for mental
health services at M. D. Anderson

Psychiatry at M. D. Anderson: Helping
patients learn to live with cancer
Patient care

Walter F. Baile is chief of
Psychiatry, Department of
Neuro-Oncology

Survival is the principal goal of cancer patients.
Emotional problems often undetected
People with cancer become immersed in a comBaile noted that although not all patients expeplex world of medical decisions and choices, all rience emotional difficulties in adjusting to their
aimed at fighting their tumors and prolonging disease, "most have some sort of emotional reactheir lives. Their days are filled with a bewildering tion, which is usually negative, at least at first.
array of diagnostic and therapeutic procedures, the There's nothing wrong with these feelings, but
rest of their time with an interminable wait for the many patients need help coming to terms with
results. And when the news is good, they often the disease. They often go without this help, howface a new set of problems as they try to resume the ever, because of their unwillingness to admit em olives they had before cancer. At the same time, tiona1 difficulties." Many patients are reluctant to
family members and loved ones juggle their own bring up their sadness or depression with their
needs with the needs of the patient and the de- . doctors because they fear the stigma. "Patients
mands of everyday life.
take personal responsibility if they are not coping
Patients, surviviors, family members-what all well," said Baile. "Some fear that if they tell the
have in common when touched by cancer are doctor, they will be labeled 'crazy.' Others don't
mental stress and emotional extremes. Their men- want to bother the doctor." Although most phytal health is threatened by the anxiety, anger, sicians treating cancer patients are sensiti e to these
frustration, and sadness they feel as they cope with
feelings, the patients' reluctance is hard to overthe disease. To promote the emotional balance come. Unrelieved, these emotional difficulties can
that leads to healing, The University of Texas worsen over time and may interfere ith a patient's
M. D. Anderson Cancer Center is offering a newly recovery.
expanded program of mental health services.
Baile sees this changing, however. He belie es
"Because survival has long been the focus of that the best way to encourage patients to accancer medicine," said Walter F. Baile,M.D., chiefof knowledge their feelings is to educate them about
Psychiatry in the Department ofNeuro-Oncology, the kinds of feelings they might have, validate
"the patient's mental health has sometimes been those feelings, and inform patients of the resources
overlooked. More and more, however, cancer paavailable to help them cope. "While patients and
tients are concerned not just with the duration of their caregivers learn about taking physical care of
-eidives-butwitlrthe-qrra:lityuftheirlives-durin-g~ -----rfre---p--ati-ent----afterdischarge;-they-shurr-I-d- a-lsu- b-e~and after treatment. Increasingly vocal cancer pa- learning to care for their mental health," he said.
tient advocacy groups are demanding attention for Baile and his colleagues are developing workshops
quality-of-life issues. We believe that a cornerstone on coping skills for patients and their families. Said
of a quality life for these patients is learning to Baile, "We're going to be more and more proactive
adjust to their disease, to manage the negative in helping the cancer patient cope and in helping
feelings they have." Because of this shift, mental the family adjust and support the patient."
health services are expected to become increasingly important in cancer centers.
continued on page 2
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"Regardless of where they are receiving
medical treatment, cancer patients can
receive mental health counseling or
therapy at M. D. Anderson."

M. D. Anderson part of "wellness"
movement
This activity is not isolated to M. D. Anderson.
Baile cited the growing "wellness" movement in
cancer care, referring to facilities within cancer
centers whose focus is the psychological rehabilitation of the patient and family. The American
Society for Psychiatry in Oncology and AIDS, a
group Baile is active in, is part of a task force that
is developing a mental health fact sheet for cancer
patients. He cited another group, the Center for
Advancement in Health in Washington, DC, whose
mission is to create awareness of psychosocial issues in cancer.
Education is just one way patients are helped in
their adjustment. Because the kinds of emotional
problems most cancer patients have are mild or
temporary, they respond well to short-term treatment, reported Baile. "We usually don't see patients who are as severely disabled as patients who
might be treated in psychiatric hospitals." These
patients are also helped by counseling, by support
from loved ones, and by participation in support
groups or by talking with another cancer patient.
All of these services are available at M. D. Anderson. Patients' family members can also receive
individual therapy. "The importance of the patient
and family members communicating their feelings
to each other can not be underestimated in helping all family members cope with the disease," said
Baile.
Because of the success of these services within
M. D. Anderson, the Psychiatry section recently
began offering them on an outpatient basis to
patients whose cancer is being treated at another
institution. Regardless of where they are receiving
medical treatment, cancer patients can receive counseling or therapy from Baile and his staff at M. D.
Anderson or participate in M. D. Anderson support groups. Physicians in the community who
treat cancer patients may refer their patients for
this therapy while continuing to manage the patients' medical treatment. (For more information
about referring a patient, see the information at
the end of this story.)
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Educating clinicians to detect depressive
disorder
Education should not be limited only to patients and their families. Baile sees a need for
increased professional education on the mental
health needs of cancer patients. This training should
include how to recognize the anxiety and depressive disorders that affect about 25% of cancer
patients (see box). "Not only do we have to educate patients to bring their emotional problems to
the physician, we have to educate the physician to
recognize the problems, which are often hidden
behind somatic complaints. Physicians need to
make the distinction between normal sadness and
depression that cancer patients feel and depressive
disorder, and they need to realize that help is
available for both. " This fall, M. D. Anderson will
offer an interviewing skills workshop for its physicians in which small groups will use role-playing,
videotaping of physician-patient interactions, and
peer feedback to encourage physicians to be more
aware of mental health problems when talking
with patients.
Continued Baile, "It is inappropriate, even dangerous, to consider depression as something that
just 'goes with the territory' of cancer. We expect
patients to feel sad or depressed, but signs of
clinical depression, what psychiatrists call depressive disorder, require professional treatment. Because depressive disorders are disabling and are
associated with poor medical outcomes, immediate attention is important."
This attention is available at M . D. Anderson .
Said Baile, "The biological revolution in psychiatry has created a class of new and very effective
medications for patients with severe emotional
problems, such as antidepressants and antianxiolytics." There is some evidence, though, that the
depressive disorders of people with physical
diseases may be different in some ways than
those of people being treated for mental health
problems only and not for physical problems. Because research on this question is just beginning,
for now the two groups are treated in much the
same ways.

-
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Baile's research centers around various techniques for improving the quality of life for both
patients and their family caregivers. One aspect of
that is improving ways for detecting mental health
pro blems. The standard written instruments for
detecting depression, for example, were designed
for physically healthy people and include physical
symptoms such as low energy and poor appetite
that are normal for many cancer patients. Use of
these instruments for cancer patients might lead to
overdiagnosis of depression in this group. He and
his colleagues are also designing studies of the
effects of mental health support to cancer patients
on their health outcomes.
Regardless of these studies' results, however,
Baile and his colleagues at M. D. Anderson have

~

seen for themselves that the mental health services
they provide help patients, survivors, and their
families release stress and handle emotions. This in
turn helps them keep a positive attitude, solve
problems, and maintain relationships. "There is a
new repertoire of skills people need to learn when
they are affected by cancer," said Baile. "By teaching those skills, we are trying to prepare patients to
cope with whatever comes at them."
-KATHRYN L. HALE
REFERRALS. Physicians wh~ have questions or would
like to refer a patient may write Dr. Baile at the Department ofNeuro-Oncology, Box 100, The University of
Texas M. D. Anderson Cancer Center, 1515 Holcombe
Blvd., Houston, Texas 77030, or call the New Patient
Referral office at (713) 792-6161 or 1-800-392-1611. ■

D EPRESSIVE DISORDER, as defined in the Ameripatients, especially those who have a history of
can Psychiatric Association's Diagnostic and Stadepressive disorder. The best way to gauge the
t istical Manual, 4th edition (popularly known as
patient's mental state is to include a few simple
DSM-4), is not simple sadness or discouragequestions in the usual medical history taking at
ment but a constellation of symptoms ranging
each visit. For example, asking the patient about
from loss of interest in usual activities to thoughts
loss of interest in usual activities may open the
of suicide.
subject. However, because patients may not volDepressive disorder is most likely to improve
unteer this information even when questioned
if it is diagnosed and treated promptly, and
directly, the clinician may want to consult family
fortunately the signs and symptoms are distincmembers or others who spend time with the
tive. The two primary signs are anhedonia, a loss
patient.
of the ability of enjoy what once gave pleasure,
Communicating the diagnosis of depressive
and repeated complaints of feeling sad or disdisorder need not be uncomfortable if the cliniheartened. Secondary signs include loss of intercian emphasizes the positive. Point out to the
est in usual activities, changes in sleep pattern,
patient that the symptoms are real, not imagiindecisiveness or inability to concentrate, low
nary, and that they are not due to progression of
self-esteem, recurrent thoughts of death or suithe cancer. Depressive disorder can be likened
cide, unexplained somatic complaints (in cancer
to other diseases characterized by biochemical
patients especially, pain out of proportion to
deficiencies.
,cii-sea-saj, iAHea-seg- ii-i-ital:)ility, tea-r-f-Y~He-s-s---Gl"-Saci- - -i;_iRally, t-t"l-e--GliRittaR-s-f-lGulci-a-s-s-1.1i-e-t-il-e--patieea-,A-1-1c'! --------- - - - - - - - - - ~
appearance, and brooding, self-pity, or pessithat most people respond fully to antidepresmism. Depressive disorder always includes at
sant medication, especially those with the mild
least one of the primary signs. In its mild form,
or moderate depression typical of cancer patients.
patients also have one of two secondary signs; in
One group of antidepressants in particular-the
its moderate form, three or four secondary signs.
serotonin re-uptake inhibitors-are useful in canThe severe form encompasses almost all of the
cer patients because they have fewer of the toxic
signs. The mild or moderate forms are typical of
effects that sometimes cause patients to stop
cancer patients struggling with their disease.
taking their antidepressant medication.
Clinicians should maintain a high index of
suspicion for depressive disorder in cancer
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Clinic works with patients and their physicians

Second opinion clinic helps patients get
the best treatment
Diagnosis

James Abbruzzese is chief
of the Section of General
Medical Oncology

Second opinions are frequently sought by patients and encouraged by physicians when an initial diagnosis is unfavorable or a recommended
treatment is complex or risky. Of course, the ideal
outcome is that the findings in the second evaluation will be more optimistic; however, even if the
second opinion is the same as the first, the patient
is usually able to face a challenging situation more
confidently after having it confirmed by another
experienced professional. Second opinions are particularly helpful in the cancer setting, because in novations in cancer medicine are being introduced
continually. In 1994, realizing the value of such a
service to both patients and community physicians, The University of Texas M. D. Anderson
Cancer Center launched a Second Opinion Clinic
to broaden its already active role in evaluating
cancer diagnoses.
Clinic a practical setting for second
opinions
M. D. Anderson Cancer Center has always
been involved in providing second opinions;
however, until this clinic opened, the institution did not have a program dedicated solely to
this service. In the past, when patients came to
M. D. Anderson for evaluation of an initial
diagnosis, physicians were pulled together from
different specialty areas to consult on the case.
Because this happened only sporadically, the
physicians and other staff often found themselves subject to conflicting demands. There was
a clear need for a more focused, efficient program. According to James Abbruzzese, M.D.,
chief of General Medical Oncology and director
of the Second Opinion Clinic, the new program
was developed to centralize the services needed
to support this special patient group. "We set
up this clinic for the express purpose of providing second opinions. Our greatest resource is
the expertise of our physicians. We structured
the new clinic to give patients who are new to
our system immediate access to M. D.
Anderson's multidisciplinary approach, allowing them to benefit from the recommendations
of several experienced specialists."
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Second opinions: the demand is growing
Approximately three to five new patients are
seen in the Second Opinion Clinic each we·ek.
Sixty percent of the patients are Texas residents;
the other 40% come from all parts of the world.
Some patients are referred by their primary care
physicians, and others are self-referred. In response
to concerns about the costs of medical care, some
insurance companies are now requiring that patients get second opinions. This trend is expected
to continue, said Abbruzzese. "We anticipate that
insurance companies will be requesting that patients get second opinions about cancer diagnoses
more and more frequently. Likewise, patients who
expect their insurance carriers to cover the cost of
cancer care will need to get a second opinion."
Because of this growing demand, Abbruzzese has
overseen development of a streamlinedpricing
schedule that will incorporate all services associated with a second opinion.
Patients can get answers after one visit
The patient consultation is conducted by one
of the physicians of the General Medical Oncology
staff. To streamline the process, patients are asked
to have their pathology, radiology, and any other
records sent to M. D. Anderson before the actual
visit. In some instances, additional tests are needed,
but usually the tests the patient has already had
are sufficient. The records are reviewed by physicians and pathologists from the appropriate specialty area. They either agree or disagree with the
initial diagnosis and treatment plan. Abbruzzese
or Lenzi will then tell the patient what these
specialists recommend. "With our new, more efficient process," explained Abbruzzese, "we can
typically consult with the other physicians by
telephone. Patients can usually get answers to
their questions in a single visit."
Abbruzzese commented that patients benefit
from the advanced technology available at M. D.
Anderson, such as fine-needle biopsy, ultrasonic
testing, comprehensive breast diagnostic testing,
and specialized interventional radiography and
continued on page 7
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On the Internet, Oncolog draws readers
from around the world
M. D. Anderson Oncolog has been available on
the Internet for nearly a year. The Internet is a
worldwide network of millions of computers. The
contents of each issue of Oncolog since January
1994 are posted on M. D. Anderson's Gopher+
and World Wide Web servers.
The response to the online version of the
Oncolog has been phenomenal. Our log of
electronic visitors shows readers from all over
the United States and the world. We have
received electronic mail from readers in European countries, Brazil, and Mexico asking for
information about our stories as well as about
M. D. Anderson, our publications, and our
activities.
We're reproducing here part of the Oncolog
title page from the World Wide Web version.
From any computer equipped with a modem and

inexpensive "Web browser" software, a few
simple keystrokes or clicks on the mouse can
take you to M. D. Anderson's "home page," site
of several publications and other information
about M. D. Anderson.
Gopher clients can access Oncolog files by
connecting to host u tmdacc. u th. tmc. edu, port
70. World Wide Web clients can connect to
http://utmdacc.uth.tmc.edu. Other M. D.

Anderson publications that can be viewed
include the Research Report 1992-1993, Hereditary
Colon Cancer Newsletter, Gynecologic Oncology
Newsletter, Current Issues in Transfusion Medicine,
and Conquest.
We welcome your comments on Oncolog and

our other publications. Send electronic mail to
khale@acadresources.mda.uth.tmc.edu.
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The goal was to find that one region. To identify
homozygous regions, the DNA was extracted from
continued from page 8
the blood of the affected children and their immediate families and compared with a purchased library of very short genetic sequences called primer
and section head Robert F. Gagel, M.D., recogpairs
which recognize a single unique chromosomal
nized that finding and characterizing the PHHI
site
whose
location is known. These primer pairs
gene would eventually yield extremely important
were
used
to
identify polymorphisms, genetic seinformation about insulin secretion and thus diabequences
that
vary
in length from person to person.
tes, one of the most prevalent and potentially dePolymerase
chain
reaction (PCR) analysis of each
stmctive chronic diseases.
person's DNA revealed who carried which polymorphisms. The researchers were looking for a
Wanted: gene carriers
polymorphism
that was carried in two different
Locating a gene requires a source of DNAusually blood or tissue specimens-from persons forms by all the family members unaffected by
PHHI and in only one form by the children with
who carry the gene. A significant problem in the
PHHI. "The polymorphisms allowed us to tell
study of PHHI genetics is the scarcity of patients
with the disease. So the researchers' first step was to which alleles each child had inherited and which
came from the mother and which from the father,"
identify children affected by the disease whose families would agree to help them in their search. By explained Cote. "From that, we looked for a pattern of inheritance of these polymorphisms in the
spreading the word to colleagues in Houston and
affected children."
beyond, Cote and Thomas were able to locate a few
After carefully recording and comparing this inchildren with the condition. They then heard from
formation for all the fanruy members, Cote, ThoP.M. Mathew, of the Dhahran Health Center in
Saudi Arabia, where the prevalence of consanguin - mas, and their colleagues found the region they
eons marriage has made PHHI more common were looking for--on the short arm of chromosome 11. Because the location of each polymorthan in the United States ( 1 in 2,675 live births
versus 1 in 50,000 live births ). (The marriage of phism is known, this analysis allowed the researchers
to pinpoint a chromosome and a region where the
two individuals with a common ancestor has a wellgene would be found. In a few more steps, using
known magnifying effect on recessive inherited disever more closely spaced markers, they were finally
orders.) Mathew had been studying the disease for
some time and was willing to collaborate on a able to narrow this region down to a single 4 million
base-pair sequence.
genetic study of the disease. He identified ten chilAfter eight months of work, the researchers had
dren with PHHI from five Saudi families and sent
whole blood san1ples from these children and their an approximate site for the PHHI gene. Their
parents and siblings to Houston. (Although Mathew finding was confirmed by complex statistical calculater identified other children affected by PHHI, lations called a linkage analysis, which shows how
closely the disease gene lies to a specific marker. In
the original ten were sufficient to complete the
this case the linkage analysis, done by Michael
genetic study.)
Hallman, Ph.D., ofThe University ofTexas School
of Public Health, revealed a high probability that
Narrowing down the location
The research group's next step was to get a this region was the site of PHHI. (This technique
is similar to that used for the highly publicized
general idea of the gene's location. They were faced
- with fu-l4m.g a sp~----iiic seqH~Ee of p~Feaps 10,-QQQ- DNA-analysis---ef blood-at1cl. other-cissues-in-er-iminal~
to 20,000 base pairs of nucleotides (the building cases.) Finding the site on chromosome 11 was
blocks of DNA) among the approximately 3 billion ironic, since the group had begun their search there.
base pairs that make up the 23 pairs of chromo- As the site of another gene for a related insulinsomes of the human genome. They used a techsecretion disorder, chromosome 11 had been a
nique called homozygosity mapping, which takes hunch that paid off.
advantage of the long regions of genetic homozygosity ( matching pairs of alleles) unique to the
Luck a factor in the discovery
DNA of persons affected by rare recessive diseases.
The group's work was not over, however, beAlthough it was likely that each affected child would cause a 4 million base-pair region contains somehave several regions of homozygosity, only one of where between 50 and 150 genes. "We took a
these regions, the one containing the disease gene,
candidate gene approach," said Cote, "looking for
would be common to all.
nearby known genes that might be related func-

Gene mapping

-

page 6

October-December 1995

tionally somehow to PHHI or insulin secretion.
Only about six genes were known in that region,
and no functional connections were apparent." The
researchers were at a loss for a starting point.
Then they got lucky. At an endocrinology research seminar at Baylor College of Medicine
(BCM), Cote and Thomas heard a presentation by
a research group at BCM who were working on the
genetics of diabetes. This group had identified the
gene that produces the receptor for the drug
sulfonylurea, which stimulates insulin production
and is used to treat adult-onset diabetes. Cote
immediately saw a possible connection between this
sulfonylurea receptor and the hypersecretion of insulin seen in PHHI. Thomas approached the BCM
researchers, who also saw the connection and agreed
to work together to find the PHHI gene. They gave
Thomas a probe, which was used to map the
sulfonylurea receptor gene by a technique called
fluorescence in situ hybridization (FISH); the gene
was found within the 4 million base-pair sequence
that had been identified for the PHHI gene.
"So we had two things," recalled Cote, "a gene
that was definitely involved in insulin secretion and
what we call a 'fish localization' showing that the
sulfonylurea receptor gene was in the exact same
place." This was more than mere coincidence, the
group decided, and they focused their attention on
the sulfonylurea gene. Genetic studies of that gene

revealed two different mutations for which PHHI affected children were homozygous, while their
parents and unaffected siblings were not. This clearly
suggested that the hypersecretion of insulin in
PHHI is caused by a mutated form of the sulfonylurea gene. The researchers concluded that the PHHI
and sulfonylurea genes are apparently one and the
same.
Cote said he still does not know exactly how this
finding will be applied clinically. "We have a better
understanding of the role of this gene in insulin
secretion and metabolism. That's an important first
step in understanding insulin regulation disorders."
His work on the sulfonylurea gene is now focused
on its significance in certain kinds of endocrine
cancers called insulinomas, which produce insulin
in an unregulated manner. And he hopes to continue collaborating with the BCM group. For Cote,
this relationships represents the ideal in interinstitutional collaboration in medical research. "It was a
team effort," he said, referring to locating the gene
for PHHI. "We couldn't have done it without our
collaborators."
-KATHRYN L. HALE
Readers who have questions may write to Dr. Cote,
Endocrine Section, Department of Medical Specialties,
Box 15, The UniversityofTexasM. D.Anderson Cancer
Center, 1515 Holcombe Blvd., Houston, Texas 77030,
or call (713) 792-2840. ■
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Second opinions
continued from page 4
nuclear imaging. "State-of-the-art equipment and
the expertise of diagnosticians who work with
cancer every day means that patients get the most
accurate assessment of their condition possible,"
he said.
ost o t e me,
erson p ysicians
concur with the original diagnosis. "In about 90%
of cases, our recommendations regarding management of a patient's condition echo what the patient
has already been told," reported Abbruzzese. "It is
actually unusual that we have a big disagreement
with an original diagnosis." Because it is a research
institution, however, M. D. Anderson is sometimes able to make suggestions for patients interested in experimental therapies. Said Abbruzzese,
"It is not the goal of this clinic to promote nontraditional approaches to cancer care; however, some
patients come to us in search of such treatments."

Program updates patients, physicians about
cancer care
One of the goals of the service is to provide
cancer patients and primary care physicians with a
general view of the treatments available for their
particular types of cancer. "This clinic was developed," Abbruzzese explained, "to educate patients
and physicians about developments in cancer care
and to reassure them that the best possible actions
a
taken to ensure die most effective, costconscious patient care."·
-VICKIE
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REFERRALS. Physicians who would like to refer
patients or patients interested in self-referrals may write
Dr. Abbruzzese at the Department of Gastrointestinal
Oncology and Digestive Diseases (Box 78 ), The University ofTexas M. D. Anderson Cancer Center, 1515
Holcombe Blvd., Houston, Texas 77030, or call the
New Patient Referral office at (713) 792 -6161 or
1-800-392-1611. ■
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Newly located gene may be key to insulin dysregulation

Technology and cooperation powerful
tools in locating genes
Genetics

Gilbert Cole is assistant
professor of medicine,
Endocrine section

With the unlocking of the genetic code, fueled
by new technologies and by projects such a the
Human Genome Project, the disco ery of disease'causing genes has become almost commonplace.
Many human diseases are now understood to be at
least partly regulated by abnormal D A, and this
decade has seen an unprecedented surge in research
efforts to identify these abnormalities. e I discovered enes are re orted on a near! dail basis
many of them heralded as the first step in the
development of a cure for the disease process they
regulate. Despite this unprecedented rate of disco ery, we can expect to hear of more and more of
these announcements; there are over 100,000 genes
in the human genome. To understand the true
significance of these discoveries, it is helpful to first
understand how genes are located.
A recent gene discovery by researchers at The
University ofTexas M. D. Anderson Cancer Center
illustrates the process. The search for the gene
began when Gilbert Cote, Ph.D., was approached
by his colleague Pamela M. Thomas, M.D., both of

the Endocrine ection, D partm nt of M di al
Specialti , about a rar inh rit d ·
in I ·ng
d regulation of in ulin er ti n.
·
ri tent hyp rin ulin mic h
·
·
(PHHI)-al o call d n idi
ized
rpr duction f in ulin and
hypogl
.
.
HHI
affec
mal C
parent. Scienti t kn v th r v a a g n that u
PHHI, but the didn't knov its lo ation or an thing about it. Thoma \J ant d to hang that.
Thomas had tv o reason for her int re t in th
PHHI gene. One v a to help childr n , ·th the
disease; PHHI is treatable if di co r d prompt!
and the hypogl cemia corrected. ntreated PHHI
can cause serious damage to the child de eloping
central nervous s stem. Identification of the g netic
abnormality v ould allm; de elopment of an , and
simpler te t for the di order. Mor o er h Cote,
continued on page 6

